BOOK
Complex Coronary Intervention, An Issue of Interventional Cardiology Clinics, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of the Interventional Cardiology Clinics edited by Michael Lee covers all key aspects of complex coronary intervention. Topics include, but are not limited to: Saphenous Vein Interventions, Atherectomy Devices for the Treatment of Calcified Lesions, Bifurcation Stenting, Chronic Total Occlusion, Multivessel Coronary Artery Disease, Management of Complications (Perforation/Dissection/Thrombosis), Antithrombotic Therapy in Percutaneous Coronary Intervention, and Acute Myocardial Infarction/Thrombectomy.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| INTERVENTIONAL CARDIOLOGY CLINICS | i | ||
| Copyright | ii | ||
| CONTRIBUTORS | iii | ||
| EDITOR-IN-CHIEF | iii | ||
| EDITOR | iii | ||
| AUTHORS | iii | ||
| CONTENTS | v | ||
| Preface: The New Era of Interventional Cardiology: Tackling Complex Coronary Intervention\r | v | ||
| Left Main Percutaneous Coronary Intervention\r | v | ||
| Saphenous Vein Graft Interventions\r | v | ||
| Atherectomy Devices for the Treatment of Calcified Coronary Lesions\r | v | ||
| Percutaneous Coronary Intervention for Bifurcation Lesions\r | vi | ||
| Update on Coronary Chronic Total Occlusion Percutaneous Coronary Intervention\r | vi | ||
| Hemodynamic Support Devices for Complex Percutaneous Coronary Intervention\r | vi | ||
| Management of Complications\r | vi | ||
| In-stent Restenosis\r | vii | ||
| Antiplatelet Therapy in Percutaneous Coronary Intervention\r | vii | ||
| Antithrombotic Therapy in Percutaneous Coronary Intervention\r | vii | ||
| Risk Stratification for Percutaneous Coronary Intervention\r | vii | ||
| Acute Myocardial Infarction/Thrombectomy\r | viii | ||
| COMPLEX CORONARY INTERVENTION | ix | ||
| FORTHCOMING ISSUES | ix | ||
| RECENT ISSUES | ix | ||
| PREFACE: The New Era of Interventional Cardiology: Tackling Complex Coronary Intervention\r | xi | ||
| Left Main Percutaneous Coronary Intervention | 125 | ||
| KEY POINTS | 125 | ||
| INTRODUCTION | 125 | ||
| CURRENT EVIDENCE | 125 | ||
| CURRENT GUIDELINES | 127 | ||
| DIAGNOSIS AND ASSESSMENT | 127 | ||
| Intravascular Imaging | 127 | ||
| Fractional Flow Reserve | 128 | ||
| PATIENT SELECTION | 129 | ||
| TECHNICAL APPROACH | 129 | ||
| Guiding Catheter | 129 | ||
| Hemodynamic Support | 129 | ||
| Lesion Preparation | 129 | ||
| Choice of Stent | 129 | ||
| Stenting Strategy | 129 | ||
| V or Y Stenting | 131 | ||
| T Stenting | 131 | ||
| The T and Protrusion Technique | 131 | ||
| Culotte Stenting | 131 | ||
| Crush Stenting Techniques | 131 | ||
| Post–Percutaneous Coronary Intervention Optimization | 131 | ||
| FOLLOWING PERCUTANEOUS CORONARY INTERVENTION | 131 | ||
| SUMMARY | 132 | ||
| REFERENCES | 132 | ||
| Saphenous Vein Graft Interventions | 135 | ||
| KEY POINTS | 135 | ||
| INTRODUCTION | 135 | ||
| PATHOPHYSIOLOGY | 135 | ||
| LESION SELECTION | 135 | ||
| INTERVENTION TECHNIQUE | 136 | ||
| Preparation | 136 | ||
| Predilation Versus Direct Stenting | 136 | ||
| Choice of Stent | 136 | ||
| Embolic Protection Devices | 137 | ||
| Distal occlusion system | 137 | ||
| Distal filtration system | 137 | ||
| Proximal occlusion system | 138 | ||
| ADJUNCTIVE PHARMACOLOGY | 138 | ||
| COMPLICATIONS DURING SAPHENOUS VEIN GRAFT INTERVENTION | 139 | ||
| SUMMARY/DISCUSSION | 139 | ||
| REFERENCES | 139 | ||
| Atherectomy Devices for the Treatment of Calcified Coronary Lesions | 143 | ||
| KEY POINTS | 143 | ||
| INTRODUCTION | 143 | ||
| PREVALENCE OF AND RISK FACTORS FOR CORONARY ARTERY CALCIFICATION | 143 | ||
| IMPACT OF CALCIUM ON PERCUTANEOUS CORONARY INTERVENTION OUTCOMES | 144 | ||
| ATHERECTOMY TREATMENT OPTIONS FOR CALCIFIED CORONARY ARTERIES | 144 | ||
| Rotational Atherectomy | 144 | ||
| Orbital Atherectomy | 144 | ||
| Laser Atherectomy | 148 | ||
| SUMMARY | 148 | ||
| REFERENCES | 148 | ||
| Percutaneous Coronary Intervention for Bifurcation Lesions | 153 | ||
| KEY POINTS | 153 | ||
| INTRODUCTION | 153 | ||
| DEFINITION AND CLASSIFICATIONS | 153 | ||
| Definition of Coronary Bifurcation Lesions | 153 | ||
| Classification of Coronary Bifurcation Lesions | 153 | ||
| Classification of Stenting Techniques | 154 | ||
| LESION CHARACTERISTICS AS PREDICTORS OF ADVERSE OUTCOME | 155 | ||
| Procedural Complications | 155 | ||
| Long-term Adverse Events | 155 | ||
| TREATMENT OPTIONS | 156 | ||
| Main Vessel Stenting with Provisional Stenting of the Side Branch Versus Systematic Two-vessel Stenting | 156 | ||
| Bioresorbable Scaffolds | 161 | ||
| Dedicated Bifurcation Stents | 162 | ||
| Kissing Balloon | 162 | ||
| The Proximal Optimization Technique | 162 | ||
| Fractional Flow Reserve | 163 | ||
| Quantitative Coronary Analysis and Intracoronary Imaging | 163 | ||
| STENTING TECHNIQUES | 163 | ||
| Provisional Stent Technique | 163 | ||
| Two-stent Techniques | 164 | ||
| Size of side branch | 164 | ||
| Lesion length in side branch | 164 | ||
| Bifurcation angulation | 164 | ||
| Calcification severity and extent | 165 | ||
| DESCRIPTION OF TWO-STENT TECHNIQUES | 165 | ||
| Culotte Technique | 165 | ||
| Crush Techniques | 165 | ||
| T-Stent Techniques | 165 | ||
| V-Stent Technique | 171 | ||
| SUMMARY | 171 | ||
| SUPPLEMENTARY DATA | 171 | ||
| REFERENCES | 171 | ||
| Update on Coronary Chronic Total Occlusion Percutaneous Coronary Intervention | 177 | ||
| KEY POINTS | 177 | ||
| INTRODUCTION | 177 | ||
| SUCCESS RATES IN CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION | 178 | ||
| ANTEGRADE WIRE ESCALATION | 178 | ||
| The Retrograde Approach | 179 | ||
| ANTEGRADE DISSECTION AND REENTRY | 180 | ||
| OPTIMAL CHOICE OF CROSSING STRATEGY | 181 | ||
| CLINICAL BENEFITS WITH CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION | 181 | ||
| SCORES FOR CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION | 182 | ||
| STENT SELECTION FOR CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION | 182 | ||
| SUMMARY | 183 | ||
| REFERENCES | 183 | ||
| Hemodynamic Support Devices for Complex Percutaneous Coronary Intervention | 187 | ||
| KEY POINTS | 187 | ||
| INTRODUCTION | 187 | ||
| DEVICES FOR HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION | 188 | ||
| Extracorporeal Membrane Oxygenation | 188 | ||
| Intra-aortic Balloon Pump | 190 | ||
| TandemHeart | 191 | ||
| Impella 2.5, Impella CP, and Impella 5.0 | 191 | ||
| DEFINITION OF HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION | 191 | ||
| CLINICAL DATA AND GUIDELINES CONCERNING HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION | 194 | ||
| Intra-aortic Balloon Pump | 194 | ||
| Extracorporeal Membrane Oxygenation | 195 | ||
| TandemHeart | 195 | ||
| Impella | 196 | ||
| PRACTICAL IMPLICATIONS AND DEVICE SELECTION | 196 | ||
| SUMMARY | 197 | ||
| REFERENCES | 198 | ||
| Management of Complications | 201 | ||
| KEY POINTS | 201 | ||
| INTRODUCTION | 201 | ||
| PERCUTANEOUS CORONARY INTERVENTION AND FOUNDATIONAL ELEMENTS OF INFORMED CONSENT | 201 | ||
| General Risks of Diagnostic Coronary Angiography | 202 | ||
| General Risks of Percutaneous Coronary Intervention | 202 | ||
| NONCORONARY COMPLICATIONS | 203 | ||
| Vascular Access Complications | 203 | ||
| Vasovagal Reactions | 203 | ||
| Other Noncoronary Complications | 203 | ||
| COMPLICATIONS OF PERCUTANEOUS CORONARY INTERVENTION | 203 | ||
| Coronary Dissection | 203 | ||
| Coronary Artery Perforation | 204 | ||
| Stent Thrombosis | 205 | ||
| No-Reflow | 206 | ||
| Embolization | 206 | ||
| Stent Loss | 206 | ||
| SUMMARY | 207 | ||
| REFERENCES | 207 | ||
| In-stent Restenosis | 211 | ||
| KEY POINTS | 211 | ||
| INTRODUCTION | 211 | ||
| CLINICAL PRESENTATION | 211 | ||
| INCIDENCE | 212 | ||
| PREDICTORS OF IN-STENT RESTENOSIS | 212 | ||
| ANATOMIC AND HEMODYNAMIC ASSESSMENT | 215 | ||
| Routine Surveillance | 215 | ||
| Intravascular Ultrasonography | 215 | ||
| Optical coherence tomography | 215 | ||
| Fractional Flow Reserve | 215 | ||
| TREATMENT | 215 | ||
| Balloon Angioplasty | 215 | ||
| Treatment with Drug-eluting Stents | 215 | ||
| Brachytherapy | 216 | ||
| Drug-coated Balloon Angioplasty | 216 | ||
| Excimer Laser Angioplasty | 216 | ||
| SUMMARY | 217 | ||
| REFERENCES | 217 | ||
| Antiplatelet Therapy in Percutaneous Coronary Intervention | 221 | ||
| KEY POINTS | 221 | ||
| INTRODUCTION | 221 | ||
| THE CENTRAL ROLE OF PLATELETS IN OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION: STENT THROMBOSIS AND BLEEDING | 222 | ||
| ANTIPLATELET AGENTS | 223 | ||
| Ticlopidine | 223 | ||
| Clopidogrel | 223 | ||
| Prasugrel | 223 | ||
| Ticagrelor | 224 | ||
| Cangrelor | 224 | ||
| Glycoprotein IIb/IIIa Inhibitors: Tirofiban, Eptifibatide, and Abciximab | 224 | ||
| CLINICAL DATA | 224 | ||
| Ticlopidine | 224 | ||
| Clopidogrel | 225 | ||
| Prasugrel | 228 | ||
| Ticagrelor | 228 | ||
| Glycoprotein IIb/IIIa Inhibitors | 228 | ||
| Cangrelor | 229 | ||
| CONTROVERSIES: PRELOADING AND PLATELET FUNCTION TESTING | 229 | ||
| Preloading with P2Y12 Inhibitors Before Percutaneous Coronary Intervention | 229 | ||
| Platelet Function Testing | 231 | ||
| GUIDELINES RECOMMENDATIONS | 233 | ||
| SUMMARY | 234 | ||
| REFERENCES | 234 | ||
| Antithrombotic Therapy in Percutaneous Coronary Intervention | 239 | ||
| KEY POINTS | 239 | ||
| INTRODUCTION | 239 | ||
| ANTITHROMBOTIC AGENTS | 240 | ||
| Unfractionated Heparin | 240 | ||
| Low-Molecular-Weight Heparin | 240 | ||
| Factor Xa Inhibitor/Fondaparinux | 242 | ||
| Director Thrombin Inhibition/Bivalirudin | 243 | ||
| OTHER AGENTS | 245 | ||
| SUMMARY | 245 | ||
| REFERENCES | 245 | ||
| Risk Stratification for Percutaneous Coronary Intervention | 249 | ||
| KEY POINTS | 249 | ||
| INTRODUCTION | 249 | ||
| THE SYNERGY BETWEEN PERCUTANEOUS CORONARY INTERVENTION WITH TAXUS AND CARDIAC SURGERY SCORE | 250 | ||
| Calculation and Variability | 250 | ||
| Derivation and Validation | 250 | ||
| The Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Score as a Tool for Decision Making | 251 | ||
| Adaptations of the Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Score and Proofs of Co ... | 251 | ||
| The Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Score II | 252 | ||
| SUMMARY | 252 | ||
| REFERENCES | 252 | ||
| Acute Myocardial Infarction/Thrombectomy | 259 | ||
| KEY POINTS | 259 | ||
| THROMBECTOMY | 259 | ||
| Mechanical Thrombectomy | 259 | ||
| Manual Thrombectomy | 261 | ||
| MULTIVESSEL CORONARY DISEASE | 262 | ||
| CARDIOGENIC SHOCK | 263 | ||
| Intra-aortic Balloon Pump | 263 | ||
| Impella | 264 | ||
| TandemHeart | 265 | ||
| Extracorporeal Membrane Oxygenation | 266 | ||
| SUMMARY | 266 | ||
| REFERENCES | 266 |